“Increases neurotrophins” is too broad when the study measured selected transcripts at different times. This Semax-and-PGP experiment provides a more specific picture. Primary report
What was observed
Rat cortex was examined after permanent middle cerebral artery occlusion. Semax and Pro-Gly-Pro produced partly overlapping transcriptional responses. With Semax, different neurotrophin or receptor genes changed at three, 24, and 72 hours; the reported pattern was not one uniform increase across all genes and times. Primary report
Our appraisal: a time course is more than a list of positive genes
A transcript measured early may have a different biological role from one measured later. Collapsing the time points into a single statement obscures the sequence the experiment was designed to examine. A useful evidence table would retain the gene, direction, tissue, comparator, and time together.
Messenger RNA also does not establish the amount of active protein at its target. Translation, processing, release, and receptor signaling are additional steps. A transcript result can motivate those measurements without substituting for them.
PGP is a fragment used in the comparison, not the same molecule as Semax. Partly overlapping effects cannot determine which fragment accounts for every whole-peptide action. That question would require comparisons designed around mechanism, exposure, and degradation.
Permanent occlusion is a specific injury model. It should not be merged automatically with studies in which blood flow is restored. Full review should examine normalization genes, sampling independence, multiple-testing decisions, and functional outcomes. The defensible contribution is a time-resolved molecular observation, not a demonstrated human stroke benefit or memory-enhancement effect.
Frequently asked questions
Was this a clinical stroke trial?
No.
Was the occlusion permanent in this model?
Yes.
Were several time points sampled?
Yes.
Did Semax and PGP have fully identical profiles?
The report described partial overlap.
Does more messenger RNA prove more active protein?
No.
Can PGP be treated as chemically identical to Semax?
No.
What should readers retain from each result?
The gene, tissue, comparison, direction, and time point.